Research
Increased Costs Associated With Proposed State Legislation Impacting PBM Tools
January 01, 2023
Visante was commissioned by the Pharmaceutical Care Management Association (PCMA) to estimate the potential cost impact of four types of...
Pharmacy Benefit Managers (PBMs): Generating Savings for Plan Sponsors and Consumers
January 01, 2023
Pharmacy Benefit Managers (PBMs) now implement prescription drug benefits for some 266 million Americans who have health insurance from a...
Pharmacy Benefit Managers (PBMs): The Return on Investment (ROI) on PBM Services
January 01, 2023
Pharmacy benefit managers (PBMs) save patients and payers an average of $1,040 per person, per year, for 275 million patients...
PCMA Statement on New Milliman Report on Insulin Coverage in Medicare Part D
June 22, 2022
Understanding beneficiaries' formulary coverage for insulin products in 2020, 2021, and 2022....
Medicare Part D 2023 Proposed Rule Could Increase Costs
March 07, 2022
New Milliman Analysis Shows Medicare Part D Proposed Rule Could Increase Premiums More than It Saves in Cost Sharing for...
Drug Manufacturer Strategies for Keeping Drug Costs High
November 16, 2021
The research firm Visante examines certain drug manufacturer anti-competitive tactics that affect many different types of prescription drugs. For example,...
Understanding Differences Between The Number of Pharmacies Reported by NCPA and NCPDP
October 29, 2021
Over the last several years, it has become increasingly apparent that there is a growing data discrepancy between reports that...
